26 Is Stereotactic ablative radiotherapy (SABR) with curative intent more cost-effective than surgical resection for early-stage non-small lung cancer (NSCLC)? New findings from the SORT study

Lung Cancer 2026

View at publisher

Authors: Richard Grieve, Eva Kagenaar, David Gibran Lugo-Palacios, Ajay Kumar Aggarwal, John Edwards, Corinne Faivre Finn

DOI: 10.1016/j.lungcan.2026.108975

Cited by: 0

References: 1

Fields of Study & Subjects

Health Systems Economic Evaluations Quality of Life Lung Cancer Diagnosis and Treatment Economic and Financial Impacts of Cancer

References 1